GlassScriptPhysician profile
Katherine Cockerill
NPI 1144607805
$4,447.39
in general payments reported to CMS, 2019-2025
30 companies · $690 in 2025
The $690 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $1,038 · 2021: $289 · 2022: $570 · 2023: $484 · 2024: $612 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,786.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $926.11 | 2020 | |
| Medtronic, INC. | $680.72 | 2021-2025 | Interstim, Nuro |
| Abbvie INC. | $360.07 | 2022-2025 | Botox |
| Coloplast Corp | $345.96 | 2020-2022 | |
| Astellas Pharma US INC | $226.57 | 2019-2025 | Xtandi |
| Olympus America INC. | $216.89 | 2019-2025 | Itind System |
| Axonics, INC. | $197.95 | 2021-2024 | Axonics |
| Janssen Biotech, INC. | $178.59 | 2021-2025 | Erleada, Akeega |
| Boston Scientific Corporation | $177.49 | 2019-2025 | Axonics, Lumenis Pulse 120h |
| Intuitive Surgical, INC. | $149.34 | 2021 | |
| Calyxo, INC. | $141.67 | 2024 | Cvac Aspiration System |
| Karl Storz Endoscopy-America | $141.43 | 2019 | |
| Conmed Corporation | $122.73 | 2019 | |
| Sumitomo Pharma America, INC. | $108.23 | 2023-2025 | Orgovyx, Gemtesa |
| Novartis Pharmaceuticals Corporation | $89.05 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $76.98 | 2019 | |
| Dendreon Pharmaceuticals LLC | $34.92 | 2025 | Provenge |
| Corcept Therapeutics | $33.57 | 2025 | Korlym |
| Stryker Corporation | $31.70 | 2022 | |
| Abc Home Medical Supply, INC. | $24.82 | 2025 | |
| Myovant Sciences INC. | $21.92 | 2022 | |
| Urogen Pharma, INC. | $19.65 | 2025 | |
| Halozyme INC | $19.12 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $18.49 | 2022 | |
| Urovant Sciences INC | $18.39 | 2022 | |
| Myriad Genetic Laboratories, INC. | $17.91 | 2025 | Prolaris |
| Allergan, INC. | $17.76 | 2022 | |
| Pfizer INC. | $17.65 | 2025 | |
| Verity Pharmaceuticals INC. | $16.83 | 2022 | |
| Tolmar, INC. | $14.88 | 2025 | Eligard, Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Cockerill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.